{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:19:33Z","timestamp":1761466773892,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.rbmo.2019.08.007","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T02:02:54Z","timestamp":1566871374000},"page":"1017-1025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Investigation of soluble anti-M\u00fcllerian hormone receptor type 2 as a biomarker for diagnosis of female fertility disorders"],"prefix":"10.1016","volume":"39","author":[{"given":"Lena Sophie","family":"Olivier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Evliyaoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-0931","authenticated-orcid":false,"given":"Ralf","family":"Weiskirchen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"van Helden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2019.08.007_bib0001","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/labinvest.2011.116","article-title":"Anti-M\u00fcllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumour cells by activating apoptosis","volume":"91","author":"Anttonen","year":"2011","journal-title":"Lab. Invest."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0002","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1210\/endo.136.11.7588229","article-title":"Anti-M\u00fcllerian hormone and anti-M\u00fcllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the oestrous cycle, and gonadotropin-induced follicle growth","volume":"136","author":"Baarends","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2019.08.007_bib0003","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.0141-9854.2003.00548.x","article-title":"Soluble transferrin receptor: a discriminating assay for iron deficiency","volume":"25","author":"Baillie","year":"2003","journal-title":"Clin. Lab. Haematol."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0004","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1210\/jc.2008-1231","article-title":"Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome","volume":"93","author":"Catteau-Jonard","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/EJE-14-0252","article-title":"European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire","volume":"171","author":"Conway","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0006","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.bbagen.2009.12.010","article-title":"Diversity of mechanisms involved in aromatase regulation and oestrogen action in the brain","volume":"1800","author":"Charlier","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.rbmo.2019.08.007_bib0007","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1038\/ncomms10055","article-title":"Novel role for anti-M\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0008","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s10815-017-1026-z","article-title":"Endometriosis-associated infertility: GDF-9, AMH, and AMHR2 genes polymorphisms","volume":"34","author":"De Conto","year":"2017","journal-title":"J Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0009","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/humrep\/dew112","article-title":"Does anti-M\u00fcllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study","volume":"31","author":"Depmann","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH anti-M\u00fcllerian hormone and oestradiol in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2019.08.007_bib0011","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1210\/me.2010-0273","article-title":"Processing of anti-M\u00fcllerian hormone releases receptor activation by a mechanism distinct of TGF-\u03b2","volume":"24","author":"di Clemente","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0012","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1054\/ghir.2001.0237","article-title":"Growth hormone signalling and its regulation: Preventing too much of a good thing","volume":"11","author":"Frank","year":"2001","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0013","doi-asserted-by":"crossref","first-page":"37101","DOI":"10.1074\/jbc.M005701200","article-title":"M\u00fcllerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism","volume":"275","author":"Ha","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0014","series-title":"Cold Spring Harb Perspect Biol.","article-title":"Signaling receptors for TGF-\u03b2 family members","author":"Heldin","year":"2016"},{"key":"10.1016\/j.rbmo.2019.08.007_bib0015","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1242\/jcs.160143","article-title":"Constitutive negative regulation in the processing of the anti-M\u00fcllerian hormone receptor II","volume":"128","author":"Hirschhorn","year":"2015","journal-title":"J. Cell Science"},{"key":"10.1016\/j.rbmo.2019.08.007_bib0016","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/humrep\/dex219","article-title":"Non-equivalence of anti-M\u00fcllerian hormone automated assays\u2013clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing","volume":"32","author":"Iliodromiti","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0017","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.febslet.2013.04.014","article-title":"The type 2 anti-M\u00fcllerian hormone receptor has splice variants that are dominant-negative inhibitors","volume":"587","author":"Imhoff","year":"2013","journal-title":"FEBS Letters"},{"key":"10.1016\/j.rbmo.2019.08.007_bib0019","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4161\/mabs.29316","article-title":"The human M\u00fcllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4","volume":"6","author":"Kersual","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.rbmo.2019.08.007_bib0020","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/humrep\/dem036","article-title":"Anti-M\u00fcllerian hormone and anti-M\u00fcllerian hormone type II receptor polymorphisms are associated with follicular phase oestradiol levels in normo-ovulatory women","volume":"22","author":"Kevenaar","year":"2007","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0021","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/molehr\/gat089","article-title":"Expression of TGF-beta superfamily growth factors, their receptors, the associated SMADs and antagonists in five isolated size-matched populations of pre-antral follicles from normal human ovaries","volume":"20","author":"Kristensen","year":"2014","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0023","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2019.08.007_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/198698","article-title":"Anti-M\u00fcllerian hormone and its clinical use in paediatrics with special emphasis on disorders of sex development","volume":"2013","author":"Lindhardt Johansen","year":"2013","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0024","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/molehr\/gav024","article-title":"Proteolytic processing of anti-M\u00fcllerian hormone differs between human fetal testes and adult ovaries","volume":"21","author":"Mamsen","year":"2015","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0025","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.fertnstert.2006.11.110","article-title":"Serum Anti-M\u00fcllerian hormone and inhibin B in disorders of spermatogenesis","volume":"88","author":"Muttukrishna","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0026","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1210\/jc.2016-1742","article-title":"Most cleaved anti-M\u00fcllerian hormone binds its receptor in human follicular fluid but little is competent in serum","volume":"101","author":"Pierre","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0027","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2017-00308","article-title":"Dysregulation of the anti-M\u00fcllerian hormone system by steroids in women with polycystic ovary syndrome","volume":"102","author":"Pierre","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0022","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diff.2017.08.002","article-title":"New insights into human female reproductive tract development","volume":"97","author":"Robboy","year":"2017","journal-title":"Differentiation"},{"key":"10.1016\/j.rbmo.2019.08.007_bib0028","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.phrs.2013.01.012","article-title":"ADAM17, shedding, TACE as therapeutic targets","volume":"71","author":"Rose-John","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0029","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10815-015-0615-y","article-title":"The anti-M\u00fcllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH","volume":"35","author":"Sacchi","year":"2016","journal-title":"J Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0031","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10815-013-0149-0","article-title":"Diagnosis of polycystic ovary syndrome: AMH in combination with clinical symptoms","volume":"31","author":"Sahmay","year":"2014","journal-title":"J Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0032","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1515\/cclm-2016-0609","article-title":"Relationship between anti-M\u00fcllerian hormone and antral follicle count across the menstrual cycle using the Beckman Coulter Access assay in comparison with Gen II manual assay","volume":"55","author":"Schiffner","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0033","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0034","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clinbiochem.2018.09.009","article-title":"Cross-method comparison of serum androstenedione measurement with respect to the validation of a new fully automated chemiluminescence immunoassay","volume":"62","author":"van Helden","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0035","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1006\/bbrc.1995.2567","article-title":"Structure and chromosomal localization of the human Anti-M\u00fcllerian hormone type II receptor gene","volume":"215","author":"Visser","year":"1995","journal-title":"Biochem. Biophys. Res. Com."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0036","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10815-014-0300-6","article-title":"Anti-Mullerian hormone as a diagnostic and prognostic tool for PCOS patients","volume":"31","author":"Wiweko","year":"2014","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2019.08.007_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203129","article-title":"Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women","volume":"13","author":"Yue","year":"2018","journal-title":"PLoS One"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319307072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319307072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:16:09Z","timestamp":1761466569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648319307072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1472648319307072"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.08.007","relation":{},"ISSN":["1472-6483"],"issn-type":[{"type":"print","value":"1472-6483"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of soluble anti-M\u00fcllerian hormone receptor type 2 as a biomarker for diagnosis of female fertility disorders","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}